When cancer patients are current smokers, their treatment is likely to be less effective and more expensive than if they quit smoking, a U.S. study suggests.

The U.S. Food and Drug Administration plans to meet with top-level executives of e-cigarette makers, the agency’s chief said, hinting that some companies seem to be backing away from commitments related to youth’s access to e-cigarettes.

The U.S. health regulator warned a California-based manufacturer and retailer against advertising its e-cigarette liquids with nicotine in a way that may cause the products to resemble kid-friendly food like juice boxes and cookies.

The FDA announced sweeping new restrictions on flavored tobacco products, including electronic cigarettes popular among teenagers in an effort to prevent a new generation of nicotine addicts.

The FDA will issue a sales ban on fruit and candy flavored electronic cigarettes in convenience stores and gas stations in a move to counter a surge in teenage use of e-cigarettes.

FCB New York, in partnership with the Food and Drug Administration, announced that the agency launched the newest evolution of “The Real Cost” youth tobacco prevention campaign.

Cancer will claim the lives of 9.6 million people in 2018, accounting for one in eight of all deaths among men and one in 11 among women, the WHO’s cancer research agency said.

People who have recently experienced a stroke may be more than twice as likely to develop dementia than individuals who have not had a stroke, a new study suggests.

Boston-based resTORbio, which was spun out of Novartis in April 2017, announced positive top-line results from the company’s Phase IIb clinical trial of RTB101 in patients with respiratory tract infections.

Exposing children to secondhand tobacco smoke increases their risk of developing habitual snoring, according to an analysis of existing research.